Essential Medical said today that it closed a $14.9 million Series B round to support the development and commercialization of its vascular closure devices. The round was led by Amzak Health and joined by prior backer Royal DSM venture investment arm DSM Venturing, the Malvern, Pa.-based company said. “We are thrilled that Amzak Health has the […]
Vascular
RFPi raises $2m angel round for blood flow imaging tech
Early-stage medical imaging company RFPi said today that it raised $2 million in an angel round to support the development of a commercial-scale model of its real-time, non-invasive blood-flow imaging device. Greenville, N.C.-based RFPi’s device is designed to show blood flow in vascular structures and critical tissues in real time during surgery, using its iCertainty platform […]
FDA approves Medtronic’s In.Pact Admiral DCB for in-stent restenosis
Medtronic (NYSE:MDT) said today it won FDA premarket approval for its In.Pact Admiral drug-coated balloon with indications for treating in-stent restenosis in peripheral artery disease patients. The Fridley, Minn.-based medical device giant touted it as the 1st DCB to be cleared to treat ISR in the U.S., saying the approval was based on results from its In.Pact global study […]
Biotronik touts dual drug-coated balloon-stent therapy for lower-limb disease
Biotronik today released data from studies of its Pulsar-18 bare metal self-expanding stent and Passeo-18 Lux drug-coated ballon, touting high rates or primary patency and freedom from target lesion revascularization in both stand-alone and combined therapy procedures in lower-limb interventions. Data from the studies was presented yesterday at the Cardiovascular and Interventional Radiological Society of […]
Avinger inks deal with HealthTrust GPO
Avinger (NSDQ:AVGR) said today it signed an agreement with group purchasing organization HealthTrust for Avinger’s portfolio of peripheral artery disease products. Get the full story at our sister site, Medical Design & Outsourcing.
Neuravi wins CE Mark for EmboTrap II stent retriever
Neuravi said today it won CE Mark approval in the European Union for its EmboTrap II stent retriever and revascularization device. The device is a next-gen version of the company’s EmboTrap, and is designed to treat a broader range of clots with sizes that are deliverable through a 0.021″ microcatheter. “The EmboTrap platform has been a […]
Balt International buys Blockade Medical
European medtech firm Balt International said today it acquired endovascular device developer Blockade Medical for an undisclosed amount. The acquisition is part of Balt’s ongoing strategy to bolster its neurovascular portfolio as well as efforts to develop a presence in the U.S., the company said. “This acquisition is a first strategic move towards transforming Balt […]
Deaths prompt FDA warning on Baxter’s Vascu-Guard patch
Updated to clarify the recent notice did not relate to a recall initiated in June 2015. The FDA today released a notice warning of issues with Baxter‘s (NYSE:BAX) Vascu-Guard peripheral vascular patch after receiving multiple adverse event reports including 3 patient deaths potentially related to the issue. The Vascu-Guard patch is designed for use in […]
Gore launches DrySeal Flex introducer sheath
W.L. Gore & Associates said today it is launching its DrySeal Flex introducer sheath designed for use with its Gore Excluder iliac branch endoprosthesis device, which is used for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms. The newly-launched device is designed with improved flexibility, kink resistance and a hydrophilic coating to […]
Bluegrass Vascular wins CE Mark for Surfacer vascular access device
Bluegrass Vascular Technologies said today that it won CE Mark approval in the European Union for its Surfacer vascular access device and plans a limited commercial launch in 7 countries there. Surfacer is designed to restore central venous access in patients with occluded veins. San Antonio-based Bluegrass Vascular, which drummed up a $4.5 million Series A round 2 years […]
Study: Drug-coated balloons beat plain balloon angioplasty in peripheral vessel disease
Drug-coated balloon treatments reduce the risk of target lesion revascularization in treating femoropopliteal artery disease by 67% when compared to plain balloon angioplasty procedures, according to a new study. Results from the study were published in the Journal of the American College of Cardiology: Cardiovascular Interventions. The study aimed to compared the risk of target […]